Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Mimedx (MDXG) Accumulated Depreciation & Amortization (2016 - 2026)

Mimedx's Accumulated Depreciation & Amortization history spans 16 years, with the latest figure at $23.9 million for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 9.09% to $23.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $23.9 million, a 9.09% increase, with the full-year FY2025 number at $23.5 million, up 10.21% from a year prior.
  • Accumulated Depreciation & Amortization hit $23.9 million in Q1 2026 for Mimedx, up from $23.5 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for MDXG hit a ceiling of $37.9 million in Q3 2023 and a floor of $20.0 million in Q4 2023.
  • Historically, Accumulated Depreciation & Amortization has averaged $27.6 million across 5 years, with a median of $23.5 million in 2025.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: rose 11.31% in 2022 and later tumbled 44.25% in 2023.
  • Tracing MDXG's Accumulated Depreciation & Amortization over 5 years: stood at $35.9 million in 2022, then tumbled by 44.25% to $20.0 million in 2023, then grew by 6.46% to $21.3 million in 2024, then rose by 10.21% to $23.5 million in 2025, then increased by 1.54% to $23.9 million in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for MDXG at $23.9 million in Q1 2026, $23.5 million in Q4 2025, and $23.0 million in Q3 2025.